AVROBIO, Inc.

https://www.avrobio.com/
Tags:BiopharmaBioTechStorage
Biotechnology company developing lentiviral-based gene therapies to treat lysosomal storage disorders (LSDs)
Location: United States, Cambridge
Total raised: $60M

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
01.02.2018Series B$60M-Avrobio Ra...

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
05.02.2018Capitalizi...Announced Thursday, the raise ...--medcitynew...
02.02.2018Term Sheet...IPO DELAYS Good morning, Term...--fortune.co...
01.02.2018Avrobio Ra...Avrobio, a Cambridge, Mass.-ba...USA-finsmes.co...
02.08.2016Avrobio Ra...Avrobio, Inc., a Cambridge, MA...USA-finsmes.co...
18.02.2016Atlas Vent...AvroBio’s second program, AV...--medcitynew...
18.02.2016Avrobio Ra...Avrobio, a Cambridge, MA and T...Canada US...-finsmes.co...